文献速递肿瘤 PET/CT放射性药物与辐射防护

极迟抗原-4在急性肺损伤中的分子影像

Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury.
PubMed 文献 · J Nucl Med · 2020-07-17

本研究在小鼠脂多糖诱导的急性肺损伤模型中,评估靶向极迟抗原-4(VLA-4)的64Cu-LLP2A PET/CT对肺部炎症的定量能力。结果显示,64Cu-LLP2A摄取主要呈支气管周围分布,与脂多糖剂量强相关(R=0.69,P<0.01),且体内摄取与多种炎症标志物及VLA-4表达显著相关。结论表明VLA-4靶向PET在小鼠模型中定量持续性肺部炎症具有可行性。

要点

  • 脂多糖滴注后肺部出现急性炎症反应,64Cu-LLP2A摄取显著且特异性地增加。
  • 体内PET定量的64Cu-LLP2A摄取与脂多糖剂量强相关(R=0.69,P<0.01)。
  • 体内64Cu-LLP2A摄取与多种炎症标志物及VLA-4表达显著相关。

核心结论

  • 研究表明,VLA-4作为急性肺损伤中机制相关的靶点,其分子影像具有可行性,VLA-4靶向PET在小鼠模型中定量持续性肺部炎症具有准确性。

研究设计与样本

  • 在C57BL/6J小鼠中经气管内单次给予脂多糖(每只10、20或40 μg)诱导急性肺损伤,对照小鼠经气管内滴注无菌磷酸盐缓冲液。
  • 在急性肺损伤诱导后第2天,静脉注射64Cu标记的高亲和力拟肽配体64Cu-LLP2A后24小时进行VLA-4靶向PET/CT。
  • 通过γ计数对 harvested 器官进行64Cu-LLP2A的离体生物分布测定,并用组织学和逆转录定量聚合酶链反应评估肺炎症严重程度。

主要发现

  • 气管内脂多糖滴注导致肺部急性炎症反应,表现为多种炎症标志物表达增加和髓系细胞浸润,同时64Cu-LLP2A摄取显著且特异性地增加,主要呈支气管周围分布。
  • 脂多糖剂量与体内PET定量的64Cu-LLP2A摄取强相关(R=0.69,P<0.01)。
  • VLA-4两个亚基(整合素α4和β1)的表达水平与多种炎症标志物(包括肿瘤坏死因子-α、白细胞介素-1β和氧化氮合酶-2)的表达显著相关。
  • 体内64Cu-LLP2A摄取与多种炎症标志物及VLA-4的表达显著相关。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammation plays a central role in the pathogenesis of acute lung injury (ALI) during both the acute pneumonitis stage and progression into the chronic fibroproliferative phase, leading to pulmonary fibrosis. Currently, there is an unmet clinical and research need for noninvasive ways to monitor lung inflammation through targeting of immunoregulatory pathways contributing to ALI pathogenesis. In this study, we evaluated the role of targeted imaging of very late antigen-4 (VLA-4), as a key integrin mediating the adhesion and recruitment of immune cells to inflamed tissues, in quantifying lung inflammation in a mouse model of lipopolysaccharide-induced ALI. Methods: ALI was induced by a single intratracheal administration of lipopolysaccharide (10, 20, or 40 μg per mouse) in C57BL/6J mice. Control mice were intratracheally instilled with sterile phosphate-buffered saline. VLA-4-targeted PET/CT was performed 24 h after intravenous injection of a 64Cu-labeled high-affinity peptidomimetic ligand referred to as 64Cu-LLP2A, which is conjugated with the chelator (1,4,8,11-tetraazacyclotetradecane-1-(methane phosphonic acid)-8-(methane carboxylic acid) and a polyethylene glycol 4 linker, at day 2 after the induction of ALI. Ex vivo biodistribution of 64Cu-LLP2A was determined by γ-counting of harvested organs. The severity of lung inflammation was assessed histologically and by measuring the expression of inflammatory markers in the lung tissue lysates using reverse transcription quantitative polymerase chain reaction. Results: Intratracheal lipopolysaccharide instillation led to an acute inflammatory response in the lungs, characterized by increased expression of multiple inflammatory markers and infiltration of myeloid cells, along with a significant and specific increase in 64Cu-LLP2A uptake, predominantly in a peribronchial distribution. There was a strong correlation between the lipopolysaccharide dose and 64Cu-LLP2A uptake, as quantified by in vivo PET (R = 0.69, P < 0.01). Expression levels of both subunits of VLA-4, that is, integrins α4 and β1, significantly correlated with the expression of multiple inflammatory markers, including tumor necrosis factor-α, interleukin-1β, and nitric oxide synthase-2, highlighting the potential of VLA-4 as a surrogate marker of acute lung inflammation. Notably, in vivo 64Cu-LLP2A uptake significantly correlated with the expression of multiple inflammatory markers and VLA-4. Conclusion: Our study demonstrates the feasibility of molecular imaging of VLA-4, as a mechanistically relevant target in ALI, and the accuracy of VLA-4-targeted PET in quantification of ongoing lung inflammation in a murine model.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Haddad J, Latoche JD, Nigam S, et al. Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury. J Nucl Med. 2020. PMID: 32680928. doi:10.2967/jnumed.120.242347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。